Really for research

Genetic research is the key to understanding how differences in our DNA can impact our health – especially cancer risk.

Here at MiraKind, we’re dedicated to conducting research in key areas to help further medical discovery and support our growing community to better understand and manage their health. One of our most impactful scientific discoveries is the KRAS-variant, which is present in up to 25% of cancer patients. But, there’s much more to learn about this and other genetic differences like the KRAS-variant.

We need your help to further our scientific studies!

This holiday, in lieu of presents, give the gift of research by giving back to science.

Here’s how it works:

  1. Select from one of our studies below
  2. Fill out our donation form
  3. Share with your friends
  4. As our studies progress, we’ll keep you informed on the results
Choose which study, or studies, you’d like to see us complete in 2018!
Cancer Survivor
autoimmuntiy icon
MIraKind KRAS-variant icon

HER-2 Positive
Breast Cancer

Autoimmunity
Research

Further
KRAS Research

Study Synopsis:

We want to discover genetic causes of Her-2 positive breast cancer risk and find genetics that predict Herceptin response.

Why it matters:

Approximately 20% of newly diagnosed breast cancers are Her-2 positive, which is considered an aggressive form of breast cancer. Women are often young, however, there are no known genetic causes of Her-2 positive breast cancer. In addition, only half of these patients will respond to the existing targeted treatments. We want to find genetic causes for these cancers, as well as improve personalize treatment.

Study Synopsis:

Autoimmunity is when a person’s immune system turns against themselves. Autoimmunity is a leading cause of death and disability, and is common, with one in five Americans suffering from autoimmunity. Autoimmunity is not evenly distributed, with 75% of those who suffer being women. The genetic causes of autoimmunity are not defined, and we want to find answers!

Why it matters:

The more we know about how genetic mutations predict autoimmunity, the more we can both predict and manage it.

Study Synopsis:

We continue to run ongoing studies to determine environmental and lifestyle factors that increase cancer risk for KRAS-variant positive patients. We know that having the KRAS-variant increases cancer risk, especially for women.

Why it matters:

Understanding the impacts of this genetic mutation helps inform KRAS-variant positive patients so that they can make the best decisions to mitigate cancer risk and advocate for their own health.